导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -6.03% | 58/76 |
| 近一周 | -2.06% | 32/84 |
| 近一月 | -2.83% | 32/85 |
| 近一季 | -1.67% | 27/85 |
| 近半年 | -0.56% | 62/78 |
| 近一年 | -7.95% | 56/74 |
| 近两年 | 24.36% | 56/70 |
| 近三年 | 37.25% | 47/62 |
| 成立以来 | 251.62% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-8.92% 62/76 |
2.92% 64/85 |
- - |
- - |
| 2025 | 19.10% 47/76 |
5.68% 14/74 |
5.42% 62/74 |
10.69% 53/74 |
-3.42% 52/76 |
| 2024 | 24.18% 22/75 |
7.66% 24/67 |
4.01% 40/72 |
9.83% 15/74 |
0.97% 37/75 |
| 2023 | 3.54% 28/72 |
1.00% 34/57 |
4.27% 32/64 |
-3.73% 29/68 |
2.13% 44/72 |
| 2022 | -14.04% 12/46 |
-13.25% 27/43 |
-2.75% 16/45 |
-6.99% 22/45 |
9.54% 15/46 |
| 2021 | -1.25% 21/43 |
2.02% 138/312 |
4.42% 142/328 |
-6.32% 190/358 |
-1.05% 21/43 |
| 2020 | 22.52% 21/41 |
-10.91% 133/280 |
23.76% 86/295 |
6.01% 85/299 |
4.82% 202/305 |
| 2019 | 30.88% 3/35 |
12.52% 81/258 |
4.45% 44/268 |
2.70% 79/253 |
8.44% 96/266 |
| 2018 | -3.54% 3/31 |
- - |
- - |
- - |
-11.52% 129/241 |
| 2017 | 30.59% 9/30 |
- - |
- - |
- - |
- - |
| 2016 | 6.09% 9/31 |
- - |
- - |
- - |
- - |
| 2015 | 10.20% 2/30 |
- - |
- - |
- - |
- - |
| 2014 | 5.94% 41/99 |
- - |
- - |
- - |
- - |
| 2013 | 19.24% 15/70 |
- - |
- - |
- - |
- - |
| 2012 | 16.63% 10/51 |
- - |
- - |
- - |
- - |
| 2011 | -18.36% 6/27 |
- - |
- - |
- - |
- - |
| 2010 | 9.27% 2/9 |
- - |
- - |
- - |
- - |
| 2009 | 64.93% 3/9 |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 诺安油气能源 | 1.4840 | 19.20% |
| 平安港股医疗优选股票(QDII)A | 0.9420 | 17.84% |
| 平安港股医疗优选股票(QDII)C | 0.9385 | 17.67% |
| 创金合信全球医药生物股票发起(QDII)C | 1.5054 | 9.47% |
| 创金合信全球医药生物股票发起(QDII)A | 1.5257 | 7.60% |
| 宏利印度股票(QDII) | 1.3125 | 3.49% |
| 宏利印度股票(QDII)C | 1.3092 | 3.41% |
| 长城港股价值优选股票(QDII)C | 0.9674 | 1.82% |
| 华宝海外科技股票(QDII-LOF)A | 2.3545 | 1.69% |
| 华宝海外科技股票(QDII-LOF)C | 2.3331 | 1.62% |
| 工银全球股票(QDII)人民币 VS. 华宝海外科技股票(QDII(501312) |